Recently diagnosed with HIV? Click here

Salvage Therapy

From HIV Tests and Treatments • 12 August 2009

Some people with HIV with significant immune impairment, or people who have taken a wide range of antiviralA medication or substance which is active against one or more viruses. May include anti-HIV drugs, but these are more accurately termed antiretrovirals. drugs over a period of many years may experience problems with their antiviral treatments because they are resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. to some classes of drugs. Treatment strategies for people who appear to have HIV that is resistant to many of the available treatments is often referred to as salvage[salvage therapy] A treatment strategy for managing HIV in people who have developed resistance to existing therapies. therapy.

There are four different salvage therapy strategies that may be tried:

  • recycling drugs – that is, using drugs you have previously used in conjunction with resistance testing to determine which ones may work best;
  • ‘mega-HAART’ regimens – using combinations of up to nine antiviral drugs – these regimens, of course, may pose serious side-effect problems;
  • ‘treatment intensification’ – adding one or two drugs to an existing regimen; and
  • accessing new treatments that have not yet been approved for wide use via compassionate access, special access schemes or by participating in clinical trials. Your doctor or treatments officer can provide you with more information about accessing these types of drugs.

Sometimes none of these strategies may be suggested or you may choose not to try them because of the side effects or risks involved. Even if you are on a regimen to which you appear to be somewhat resistant, your doctor may recommend you continue on it as it still may provide protection and help to keep you healthy.

HIV Tests and Treatments

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

The article you are viewing is part of the larger (multi-page) resource HIV Tests and Treatments.

View the introductory page.

In stock. Printed copies of this resource are available from the NAPWA office. Contact NAPWA if you would like a copy mailed to you.

This Resource was first published on 12 August 2009 — more than two years ago.

While the content of this resource was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.